Antiproliferative Evaluation In Vitro of a New Chalcone Inducing Apoptosis by ROS Generation Against MGC-803 Cells
- Авторы: Fu D.1, Li J.1, Li P.1, Cui Z.2,3, Zhang S.4, Li J.4
 - 
							Учреждения: 
							
- School of Pharmaceutical Sciences & Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University
 - School of life Sciences, Institute of Biodiversity and Ecology, Zhengzhou University
 - Charles Perkins Centre, Sydney Medical School, University of Sydney
 - School of Basic Medicine, Zhengzhou University
 
 - Выпуск: Том 53, № 6 (2019)
 - Страницы: 539-543
 - Раздел: Article
 - URL: https://journals.rcsi.science/0091-150X/article/view/245855
 - DOI: https://doi.org/10.1007/s11094-019-02034-8
 - ID: 245855
 
Цитировать
Аннотация
We have evaluated the antiproliferative activity of (E)-3-(3,5-difluorophenyl)-1-(2,4,6-trimethoxyphenyl)- prop-2-en-1-one (chalcone 5) against MGC-803 cells. This chalcone analog displayed a potent antiproliferative activity with an IC50 value of 0.23 μM against MGC-803 cells. It could induce apoptosis and regulate the apoptosis-related markers (Bax, Bcl-2, Bcl-xl, and Bid) in a concentration dependent manner. Treatment with NAC almost completely attenuated chalcone-induced cell inhibition and cell apoptosis in MGC-803 cells, indicating that the apoptotic mechanisms were related to ROS generation. Therefore, this chalcone derivative is a new apoptosis inducer for prevention and treatment of gastric cancer.
Об авторах
Dong-Jun Fu
School of Pharmaceutical Sciences & Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University
														Email: fade3532@163.com
				                					                																			                												                	Китай, 							Zhengzhou, 450001						
Jia-Huan Li
School of Pharmaceutical Sciences & Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University
														Email: fade3532@163.com
				                					                																			                												                	Китай, 							Zhengzhou, 450001						
Ping Li
School of Pharmaceutical Sciences & Collaborative Innovation Center of New Drug Research and Safety Evaluation, Zhengzhou University
														Email: fade3532@163.com
				                					                																			                												                	Китай, 							Zhengzhou, 450001						
Zhen-Wei Cui
School of life Sciences, Institute of Biodiversity and Ecology, Zhengzhou University; Charles Perkins Centre, Sydney Medical School, University of Sydney
														Email: fade3532@163.com
				                					                																			                												                	Китай, 							Zhengzhou, 450001;  Camperdown, Sydney, New South Wales, 2006						
Sai-Yang Zhang
School of Basic Medicine, Zhengzhou University
														Email: fade3532@163.com
				                					                																			                												                	Китай, 							Zhengzhou, 450001						
Jiang-Feng Li
School of Basic Medicine, Zhengzhou University
							Автор, ответственный за переписку.
							Email: fade3532@163.com
				                					                																			                												                	Китай, 							Zhengzhou, 450001						
Дополнительные файлы
				
			
						
					
						
						
						
									